Johnson & Johnson Gets CDSCO Panel Nod to Study anti-cancer drug Amivantamab Dr. Divya Colin26 Oct 2024 5:30 PM ISTNew Delhi: The drug major Johnson & Johnson has got approval from the Subject Expert Committee (SEC) functional under the Central Drug Standard...
MSN Laboratories gets CDSCO Panel nod to conduct Bioequivalence Study of Abiraterone Tablets1000mg Dr. Divya Colin18 Aug 2024 5:45 PM ISTNew Delhi: MSN Laboratories has got the go-ahead from the Subject Expert Committee (SEC) functional under the Central Drug Standard Control...
Bristol Myers Squibb India Gets CDSCO Panel Nod to Study anticancer drug Mezigdomide Dr. Divya Colin17 Aug 2024 6:00 PM ISTNew Delhi: The drug major Bristol-Myers Squib has got approval from the Subject Expert Committee (SEC) functional under the Central Drug Standard...
CDSCO Panel Approves AstraZeneca's Protocol Amendment Proposal to Study anti-cancer Drug Capivasertib Dr. Divya Colin28 July 2024 6:15 PM ISTNew Delhi: The Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organization (CDSCO) has approved AstraZeneca's...
Novartis Healthcare Gets CDSCO Panel Nod to Study Asciminib Filmcoated Tablets Dr. Divya Colin28 July 2024 6:00 PM ISTNew Delhi: Suggesting to add more government sites, the Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organization...
Zydus Life Sciences Gets CDSCO Panel Nod to Study anti-cancer drug Relugolix Dr. Divya Colin27 July 2024 6:00 PM ISTNew Delhi: The drug major Zydus Lifscience has got approval from the Subject Expert Committee (SEC) functional under the Central Drug Standard Control...
CDSCO Panel Approves Johnson and Johnson's Protocol Amendment Proposal to study anti-cancer drug Amivantamab Dr. Divya Colin14 July 2024 5:30 PM ISTNew Delhi: The Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organization (CDSCO) has approved the drug major...
Intas Pharmaceuticals Gets CDSCO Panel Nod for Palatability Study of Temozolomide powder for oral suspension Dr. Divya Colin13 July 2024 6:00 PM ISTNew Delhi: The drug major Intas Pharmaceuticals has got approval from the Subject Expert Committee (SEC) functional under the Central Drug Standard...
Roche Products India gets CDSCO Panel Nod To study anti-cancer drug Pralsetinib Capsule Dr. Divya Colin12 July 2024 6:00 PM ISTNew Delhi: The drug major Roche Products India has got approval from the Subject Expert Committee (SEC) functional under the Central Drug Standard...
Zydus Lifscience Gets CDSCO Panel Nod to Manufacture, Market Nivolumab for Metastatic Non-small Cell Lung Cancer Dr. Divya Colin7 July 2024 6:00 PM ISTNew Delhi: In a significant development, the drug major Zydus Life Sciences has got the go-ahead from the Subject Expert Committee (SEC) functional...
AstraZeneca Pharma India gets CDSCO Panel Nod to study anti-cancer drug Datopotamab deruxtecan/Rilvegostomig Dr. Divya Colin6 July 2024 6:00 PM ISTNew Delhi: The drug major AstraZeneca Pharma India has got the go-ahead from the Subject Expert Committee (SEC) functional under the Central Drug...
Expansion of warning statement may be considered after submission of first year PSUR data: CDSCO panel on AstraZeneca's anticancer drug Dr. Divya Colin25 Jun 2024 10:28 PM ISTNew Delhi: Noting that Tremelimumab Concentrate for Solution for infusion 20 mg/ml is not yet launched in the Indian market, the Subject Expert...
